Role of growth hormone signaling pathways in the development of atherosclerosis

The direct actions of growth hormone (GH) in the development of atherosclerosis are unclear. The goal of this study was to characterize GH-induced changes in expression of signaling pathway elements and other proteins that may be related to atherosclerosis. Human umbilical vein endothelial cells (HU...

Full description

Saved in:
Bibliographic Details
Published inGrowth hormone & IGF research Vol. 53-54; p. 101334
Main Authors Ishikawa, Mayumi, Toyomura, Junko, Yagi, Takashi, Kuboki, Koji, Morita, Toshisuke, Sugihara, Hitoshi, Hirose, Takahisa, Minami, Shiro, Yoshino, Gen
Format Journal Article
LanguageEnglish
Published Scotland Elsevier Ltd 01.08.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The direct actions of growth hormone (GH) in the development of atherosclerosis are unclear. The goal of this study was to characterize GH-induced changes in expression of signaling pathway elements and other proteins that may be related to atherosclerosis. Human umbilical vein endothelial cells (HUVEC) and THP-1, a human acute monocytic leukemia cell line, were stimulated by exposure to 10−9 M or 10−8 M human GH with or without pretreatment with a mitogen-activated protein kinase kinase (MEK) 1 inhibitor. Levels of transcripts encoding vascular cell adhesion molecule (VCAM) -1, E-selectin, monocyte chemotactic protein (MCP-1), interleukin (IL) -6, and IL-8 were investigated by reverse transcription (RT) -PCR. For the quantitative adhesion assay, THP-1 cells or human primary monocytes were fluorescently labeled with 3’-O-acetyl-2′,7′-bis(carboxyethyl) -4 diacetoxymethyl ester (BCECF/AM). HUVEC treated with human GH were co-incubated with BCECF-labeled THP-1 cells. One hour later, the number of BCECF-labeled THP-1 cells was assessed. An equivalent experiment was performed using BCECF-labeled primary monocytes, and the number of monocytes adhering to HUVEC was counted. Treatment with hGH increased the levels of E-selectin- and VCAM-1-encoding mRNAs in HUVEC. This effect was attenuated by pretreatment with a MEK1 inhibitor. Furthermore, hGH treatment increased adhesion of BCECF-labeled THP-1 cells or primary monocytes to HUVEC, and this effect was attenuated by pretreatment with a MEK1 inhibitor. VCAM-1 and E-selectin expression was stimulated by GH via the mitogen-activated protein kinase pathway, resulting in augmented adhesion of THP-1 cells and monocytes to HUVEC. These data suggested that GH directly stimulates the development of atherosclerosis. •GH increased mRNA expressions of VCAM-1 and E-selectin on HUVEC.•The GH effects were suppressed by MEK-1 inhibitor, but not by JAK2 inhibitor.•GH increased THP-1, which is human acute monocytic leukemia cell line, attachment to HUVEC.•The attachment was suppressed by MEK1 inhibitor.•These data suggest that GH stimulates development of atherosclerosis via srk-erk pathway without IGF-I.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1096-6374
1532-2238
DOI:10.1016/j.ghir.2020.101334